 NEW YORK, Aug. 3, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Translate Bio, Inc. Translate or the Company NASDAQ: TBIO in connection with the proposed acquisition of the Company by Sanofi Sanofi NASDAQ: SNY via a tender offer. Under the terms of the merger agreement, the Companys shareholders will receive 38.00 in cash for each share of Translate common stock that they hold. 